Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Stomach Neoplasms × Acetylcysteine × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ulcer 1 Tomaculous neuropathy 1 Thrombocythemia, Essential 1 Stomatitis 1 Stomach Neoplasms 1 Radiation Pneumonitis 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Polycystic Ovary Syndrome 1 Neuroma 1 Myeloproliferative Disorders 1 Median Neuropathy 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Hand Injuries 1 Disease 1 Carpal Tunnel Syndrome 1

Interventions

Oxaliplatin 38 Fluorouracil 27 pembrolizumab 21 Capecitabine 21 Paclitaxel 18 Leucovorin 17 S 1 (combination) 14 Docetaxel 13 tislelizumab 11 Nivolumab 11 Cisplatin 10 sintilimab 9 Trastuzumab 9 Irinotecan 9 trastuzumab deruxtecan 8 Drug Therapy 8 Biopsy 8 Surgical Procedures, Operative 7 Specimen Handling 7 Bevacizumab 7 fludarabine 6 disitamab vedotin 6 apatinib 6 XELOX 6 Radiotherapy 6 Magnetic Resonance Spectroscopy 6 Hyperthermic Intraperitoneal Chemotherapy 6 Cyclophosphamide 6 spartalizumab 5 lenvatinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07245095 2025-11-24

NACSIMET

Hospital General de Mexicali

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡